Derek Dirocco

Director, 89bio, Inc.

Companies

Evommune, Inc.Board member Nov 5, 2025 to now¹
Mineralys Therapeutics, Inc.Board member Feb 9, 2023 to now²
Acrivon Therapeutics, Inc.Board member Nov 9, 2022 to now³
89bio, Inc.Board member Nov 8, 2019 to now⁴
Werewolf Therapeutics, Inc.Board member Apr 29, 2021 to May 24, 2024⁵
iTeos Therapeutics, Inc.Board member Jul 23, 2020 to Jun 15, 2023⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Mineralys Therapeutics, Inc. MLYS6,200 shares⁷$129.8K at $20.93Feb 19, 2026
Acrivon Therapeutics, Inc. ACRV9,366 shares⁸$15.9K at $1.70May 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 18, 2026Granted 9,366 shares of Acrivon Therapeutics, Inc.⁸
Feb 19, 2026Granted 6,200 shares of Mineralys Therapeutics, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREvommune, Inc., Board member
2
SEC EDGARMineralys Therapeutics, Inc., Board member
3
SEC EDGARAcrivon Therapeutics, Inc., Board member
4
SEC EDGAR89bio, Inc., Board member
5
SEC EDGARWerewolf Therapeutics, Inc., Board member
6
SEC EDGARiTeos Therapeutics, Inc., Board member
7
SEC EDGARMineralys Therapeutics, Inc. shares after the filing of Feb 19, 2026
8
SEC EDGARAcrivon Therapeutics, Inc. shares after the filing of May 18, 2026